论文部分内容阅读
Background & Aims Liver histological assessment is essential for predicting antiviral therapy in HBeAg negative chronic hepatitis B (CHB) patients with serum alanine aminotransferase (ALT) ≤ 2 upper limit of normal (ULN).The aim of our study is to establish a model to predict antiviral treatment for those patients without liver biopsy.